Image

Europe Foot and Ankle Allografts Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Apr 2022
  • Europe
  • 350 Pages
  • No of Tables: 140
  • No of Figures: 36
  • Medical Devices
  • Published Report
  • Apr 2022
  • Europe
  • 350 Pages
  • No of Tables: 140
  • No of Figures: 36

Europe Foot and Ankle Allografts Market, By Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, Amniotic Membranes), Surgery Type (Orthopaedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon and Ligament Repair, Wound Care), Procedure (Midfoot Procedures, Hindfoot Procedures) End-User (Hospitals, Orthopaedic Clinics, Ambulatory Surgical Centres, Academic and Research Institutes, Other End Users) – Industry Trends and Forecast to 2029.

Europe Foot and Ankle Allografts Market

Europe Foot and Ankle Allografts Market Analysis and Insights

Foot and ankle allografts market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the Europe market is growing with a CAGR of 9.1% in the forecast period of 2022 to 2029 and is expected to reach USD 330.48 million by 2029 from USD 161.27 million in 2021. Rising prevalence of orthopedic diseases and foot and ankle disorders, along with the increase in continuous product commercialization and rising geriatric population; are the major drivers which propelled the demand of the market in the forecast period.

Europe Foot and Ankle Allografts Market

Europe Foot and Ankle Allografts Market

High costs associated with foot and ankle allograft devices and lack of formal education and training may hamper the future growth of foot and ankle allografts market. The partnerships and acquisitions by major market players act as opportunity for the growth of foot and ankle allografts market.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, Amniotic Membranes), Surgery Type (Orthopaedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon and Ligament Repair, Wound Care), Procedure (Midfoot Procedures, Hindfoot Procedures) End-User (Hospitals, Orthopaedic Clinics, Ambulatory Surgical Centres, Academic and Research Institutes, Other End Users)

Countries Covered

Germany, France, U.K., Italy, Spain, Turkey, Russia, Netherlands, Switzerland, Belgium and Rest of Europe

Market Players Covered

CONMED Corporation (U.S.), Wright Medical Group N.V. (U.S.), Arthrex (U.S.), Integra LifeSciences (U.S.), Smith+Nephew (UK), Zimmer Biomet (U.S.), AlloSource (U.S.), Amniox Medical, Inc. (U.S.), RTI Surgical Holdings, Inc. (U.S.), JRF Ortho (U.S.), Bone Bank Allografts (U.S.),  Smith & Nephew. (UK), Paragon 28 (U.S.), Bioventus, (U.S.), NVision Biomedical Technologies (U.S.), DePuy Synthes Companies (U.S.)

Foot and Ankle Allografts Market Dynamics

  • Growing Geriatric Population

Geriatric population are more prone to the conditions leading to fragile bones and joints. In such patients allografts are used in the procedure to provide them immediate and efficient benefits associated with their body.

  • Increasing Incidence of Musculoskeletal Disorder

Musculoskeletal disorders comprises of fractures associated with bone fragility, osteoarthritis, injuries and systemic inflammatory conditions such as rheumatoid arthritis. Allografts have been used to correct these deformities or to fill bone defects secondary to trauma, osteochondral lesions, or intercalary arthrodesis.

Restraint

  • Stringent Regulatory Guidelines

The allografts are regulated by a structure of laws, rules, and regulations that are extensive and complex to safeguard them from use in any potential harmful treatment. The need for more stringent privacy policies and regulations has limited the growth of this market

Opportunity

  • Increasing Reimbursement Policies

Increasing Universal Health Coverage (UHC) is widely believed to drive better patient accessibility to healthcare systems. Moreover, a number of organizations have initiated reimbursement policies. The policies programs help in covering healthcare needs of population are expected to create a significant opportunity for the market.

Challenge

  • Lack of Awareness for Foot and Ankle Solutions

A large number of population suffers from foot and ankle cases in underdeveloped countries. These cases tend to get neglected or mismanaged, as ankle orthopedics has yet to establish itself as the specialty of orthopedics in developing countries. Moreover, lack of knowledge about the availability of foot and ankle solutions in society as well as in medical population pose as a major challenge for the market.

The Foot and ankle allografts market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Post COVID-19 Impact on Foot and Ankle Allografts Market

COVID-19 has resulted in a substantial upsurge in demand for medical supplies from both healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the allograft market for feet and ankles.

Foot and Ankle Allografts Market Scope and Market Size

Foot and ankle allografts market is segmented on the basis of product type, surgery type, procedure, end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Product Type

  • Allograft Wedges
  • Allograft Tendons
  • Allograft Acellular Dermal Matrix
  • Cartilage Allograft Matrix
  • Skin Allografts
  • Amniotic Membranes

On the basis of product type market is segmented into allograft wedges, allograft tendons, allograft acellular dermal matrix, cartilage allograft matrix, skin allografts, amniotic membranes.

Surgery Type

  • Orthopaedic Reconstruction
  • Cartilage Restoration
  • Soft Tissue Tendon and Ligament Repair
  • Wound Care

On the basis of surgery type the market is segmented into orthopaedic reconstruction, cartilage restoration, soft tissue tendon and ligament repair, wound care.

Procedure

  • Midfoot Procedures
  • Hindfoot Procedures

On the basis of procedure the market is segmented into midfoot procedures, and hindfoot procedures.

End User

  • Hospitals
  • Orthopaedic Clinics
  • Ambulatory Surgical Centres
  • Academic and Research Institutes
  • Other End Users

Europe Foot and Ankle Allografts Market

On the basis of end user the market is segmented into hospital, orthopaedic clinics, ambulatory surgical centres, academic and research institutes, other end users.

Foot and Ankle Allografts Market Country Level Analysis

The foot and ankle allografts market is analyzed and market size information is provided by product type, surgery type, procedures and end user.

The countries covered in the foot and ankle allografts market report are the Germany, France, U.K., Italy, Spain, Turkey, Russia, Netherlands, Switzerland, Belgium and Rest of Europe.

In 2022, Europe is dominating due to the increasing geriatric population. Germany is expected to grow due to rise in continuous product commercialization.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Foot and ankle allografts market also provides you with detailed market analysis for every country growth in foot and ankle allografts market industry. Moreover, it provides detailed information regarding foot and ankle allografts market sales, impact of regulatory scenarios, and trending parameters regarding Foot and ankle allografts market. The data is available for historic period 2011 to 2020.

Competitive Landscape and Foot and Ankle Allografts Market Share Analysis

Foot and ankle allografts market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to foot and ankle allografts market.

The major companies which are dealing in the foot and ankle allografts market are CONMED Corporation (U.S.), Wright Medical Group N.V. (U.S.), Arthrex (U.S.), Integra LifeSciences (U.S.), Smith+Nephew (UK), Zimmer Biomet (U.S.), AlloSource (U.S.), Amniox Medical, Inc. (U.S.), RTI Surgical Holdings, Inc. (U.S.), JRF Ortho (U.S.), Bone Bank Allografts (U.S.),  Smith & Nephew. (UK), Paragon 28 (U.S.), Bioventus, (U.S.), NVision Biomedical Technologies (U.S.), DePuy Synthes Companies (U.S.), and others

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Europe Vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


SKU-
Why Choose Us


Frequently Asked Questions

The Europe Foot and Ankle Allografts Market will be projected to grow at a CAGR of 9.1% during forecast by 2029.
The Europe Foot and Ankle Allografts Market will be projected at USD 330.48 million during forecast by 2029.
The significant factors flourishing the growth of the Europe Foot and Ankle Allografts Market are Growing Geriatric Population and Increasing Incidence of Musculoskeletal Disorder.
The major players operating in the Europe Foot and Ankle Allografts Market are CONMED Corporation (U.S.), Wright Medical Group N.V. (U.S.), Arthrex (U.S.), Integra LifeSciences (U.S.), Smith+Nephew (UK), Zimmer Biomet (U.S.), AlloSource (U.S.), Amniox Medical, Inc. (U.S.), RTI Surgical Holdings, Inc. (U.S.), JRF Ortho (U.S.), Bone Bank Allografts (U.S.), Smith & Nephew. (UK), Paragon 28 (U.S.), Bioventus, (U.S.), NVision Biomedical Technologies (U.S.), DePuy Synthes Companies (U.S.).